Reuters logo
BRIEF-Lexicon Pharmaceuticals says Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network
June 19, 2017 / 11:21 AM / 5 months ago

BRIEF-Lexicon Pharmaceuticals says Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network

June 19 (Reuters) - Lexicon Pharmaceuticals Inc

* Lexicon Pharmaceuticals Inc - Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network

* Lexicon Pharmaceuticals Inc - Xermelo has also been included in NCCN Drugs & Biologics Compendium Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below